Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
$86.28
Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
31 Oct 2025, 11:49
Chart & Data from IG
Meta Platforms Inc. (NASDAQ: META) is once again under the spotlight as its share price approaches a significant resistance level, creating tension among investors. The stock recently tested its all-time high of $740.83, briefly climbing to $748.87, only to close the weekly candlestick lower at $711.79.
As of the latest pre-market session, Meta shares are trading around $722.36, with investor sentiment closely tied to the upcoming tariff deadline. While some countries have received extensions until 1st August, the market has yet to fully price in the potential impact. This adds further uncertainty ahead of Meta’s Q2 earnings report, expected in the coming weeks.
From a technical standpoint, the stochastic oscillator indicates that Meta stock is overbought in the short term. This overextension may have contributed to last week’s lower close and could continue to influence trading in the days ahead.
The immediate support level now sits at $711.79—last week’s low. A decisive break below this level could see a further pullback towards $678.98, a previous consolidation zone.
Conversely, if the stock manages to break above the newly formed resistance at $748.87, bullish momentum could push Meta’s share price towards the psychological target of $800.
With major macroeconomic events and earnings season on the horizon, Meta’s stock performance may remain range-bound until new catalysts emerge. The upcoming earnings announcement could provide the necessary impetus for a breakout, potentially reshaping the stock's trajectory during the summer months.